In ₹ Crore except Per Share 12 Months Ending | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | |
|---|---|---|---|---|---|---|
| Revenue from Operations | 83.6 | 89.2 | 81.3 | 87.4 | 98.7 | |
| Other Income | 6.8 | 12.6 | 16.1 | 14.5 | 17.1 | |
| Total Income | 90.5 | 101.8 | 97.4 | 102.0 | 115.8 | |
| Expenses | ||||||
| + Cost of Materials Consumed | 0.9 | 0.9 | 1.1 | 1.0 | 1.1 | |
| + Purchases of Stock-in-Trade | 7.8 | 10.4 | 8.6 | 9.3 | 9.9 | |
| + Changes in Inventories | 0.6 | -2.9 | 0.5 | 1.3 | -0.4 | |
| + Employee Benefit Expense | 6.3 | 6.5 | 7.0 | 8.3 | 7.3 | |
| + Finance Costs | 4.6 | 1.1 | 1.5 | 2.3 | 2.0 | |
| + Depreciation & Amortisation | 5.1 | 5.1 | 5.2 | 6.1 | 6.3 | |
| + Other Expenses | 37.3 | 40.8 | 39.3 | 40.4 | 43.2 | |
| Total Expenses | 62.6 | 61.8 | 63.2 | 68.7 | 69.3 | |
| EBITDA | 30.7 | 33.5 | 24.9 | 27.2 | 37.6 | |
| EBIT | 25.6 | 28.4 | 19.6 | 21.1 | 31.4 | |
| Profit | ||||||
| PBT before Exceptional Items | 27.8 | 40.0 | 34.2 | 33.3 | 46.5 | |
| Pretax Income | 27.8 | 40.0 | 34.2 | 33.3 | 46.5 | |
| + Current Tax | 5.7 | 7.8 | 6.4 | 3.5 | 9.4 | |
| + Deferred Tax | 3.4 | -4.5 | 1.7 | 6.9 | 2.1 | |
| Tax Expense | 9.1 | 3.2 | 8.1 | 10.4 | 11.5 | |
| Net Income | 18.7 | 36.7 | 26.1 | 22.9 | 35.0 | |
| + Net Income — Continuing Ops | 18.7 | 36.7 | 26.1 | 22.9 | 35.0 | |
| + Other Comprehensive Income | -0.1 | -0.6 | 0.0 | 0.5 | 0.1 | |
| Total Comprehensive Income | 18.7 | 36.1 | 26.1 | 23.4 | 35.0 | |
| Per Share | ||||||
| Basic EPS | 1.42 | 2.61 | 1.85 | 1.62 | 2.48 | |
| Diluted EPS | 1.42 | 2.61 | 1.85 | 1.62 | 2.48 | |
| Other Comprehensive Income — detail | ||||||
| + Other Comprehensive Income | -0.1 | -0.6 | 0.0 | 0.5 | 0.1 | |
| + Items NOT to be Reclassified to P&L | -0.1 | -0.1 | 0.0 | 0.3 | 0.1 | |
| + Tax on Items NOT to be Reclassified | -0.0 | 0.6 | -0.0 | -0.2 | 0.0 | |
| Per Share — as-filed variants | ||||||
| Basic EPS — Continuing Operations | 1.42 | 2.61 | 1.85 | 1.62 | 2.48 | |
| Diluted EPS — Continuing Operations | 1.42 | 2.61 | 1.85 | 1.62 | 2.48 | |
| Regulatory Disclosures — filed alongside, not part of the P&L | ||||||
| Related-party Transactions — During the Period | — | 23,44,750.9 | — | 53,71,254.8 | — | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | ||||||
| Gross Profit | 74.3 | 80.8 | 71.1 | 75.8 | 88.2 | |
| Gross Margin % | 88.85 | 90.58 | 87.41 | 86.73 | 89.32 | |
| Adjusted (ex-Exceptional Items) — derived | ||||||
| Pretax Income (Adjusted, as filed) | 27.8 | 40.0 | 34.2 | 33.3 | 46.5 | |
| Net Income Adj (tax-effected) | 18.7 | 36.7 | 26.1 | 22.9 | 35.0 | |
| EPS Adj | 1.42 | 2.61 | 1.85 | 1.62 | 2.48 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | ||||||
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | |
| Filed Debt Equity | 0.28 | 0.12 | 0.14 | 0.18 | 0.19 | |
| Filed Dscr | 4.38 | 0.35 | 3.07 | 2.62 | 4.80 | |
| Filed Iscr | 7.04 | 17.99 | 8.35 | 9.03 | 24.80 | |
| Paid Up Equity Capital | 28.2 | 28.2 | 28.2 | 28.2 | 28.2 | |